Muhammad Umair Mushtaq, John F. DiPersio, Jacques Azzi, Brenda W. Cooper, Guenther Koehne, Divya Koura, Joseph Maakaron, John Magenau, Brian McClune, Joseph C. Rimando, Nirali N. Shah, Hyung C. Suh, Kelly Beuka, John Sturrock, Mugdha Nikam, Eric Berglund, Jianxin Hu, Yonina Keschner, Julia Etchin, John R. Lydeard, Michele Vasquez, David O’Donnell, Guy Mundelboim, Sanjana Thosar, Giacomo Canesin, Juliana Xavier-Ferrucio, Sharon L. Hyzy, Deborah M. Lloyd, Kristin Spink, Diana Hummel, Melissa M. Lee-Sundlov, Julian Scherer, Michelle I. Lin, Jennifer S. Whangbo, Lori S. Muffly. "A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT." Blood, 2026. doi:10.1182/blood.2025031053